NAV
₹51.5370
as of 31 Jul 2026
Expense Ratio
—
see scheme documents
Lumpsum returns (CAGR)
- 1Y
- +16.16%
- 3Y
- +23.77%
- 5Y
- +16.11%
- Since Inception
- +22.50%
SIP returns (XIRR)
- 1Y
- +32.19%
- 3Y
- +21.61%
- 5Y
- +21.20%
- Since Inception
- +22.89%
Performance Comparison
Sectoral allocation
as of 30 Jun 2026Each sector links to the mutual funds most exposed to it.
Thinking about Mirae Asset Healthcare Fund · Direct · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Portfolio holdings
portfolio shared with Mirae Asset Healthcare Fund Regular IDCW
- 1Sun Pharmaceutical Industries Ltd.10.95%
- 2Divi'S Laboratories Ltd.7.53%
- 3Jb Chemicals & Pharmaceuticals Ltd.6.49%
- 4Apollo Hospitals Enterprise Ltd.6.09%
- 5Glenmark Pharmaceuticals Ltd.6.09%
- 6Laurus Labs Ltd.4.61%
- 7Dr. Reddy'S Laboratories Ltd.4.33%
- 8Aurobindo Pharma Ltd.4.33%
- 9Lupin Ltd.4.13%
- 10Krishna Institute Of Medical Sciences Ltd.3.85%
Investment Objective
Mirae Asset Healthcare Fund · Direct · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
Mirae Asset Healthcare Fund · Direct · Growth is a Sectoral / Thematic mutual fund offered by Mirae Asset Mutual Fund. The fund has been operational for over 8 years.
Who Should Invest?
- •Investors with a high risk appetite seeking long-term wealth creation
- •Investors with an investment horizon of 5 years or more
- •SIP investors who can benefit from rupee cost averaging during market fluctuations